Researchers have developed a test that spots early signs of Alzheimer's disease. Rather than looking for amyloid-beta plaques ...

House Bill 8, has been introduced in Ohio with the goal of expanding private insurance and Medicaid coverage for biomarker ...

Alzheimer’s disease, the most common form of dementia affecting more than three million Americans a year, has proven difficult to diagnose in earlier stages. But detecting and treating the condition ...

Scientists have identified a biomarker for Alzheimer's that may help doctors spot the early signs of protein buildup in the ...

“Prostate-specific membrane antigen (PSMA) PET imaging can identify patients suitable for PSMA-targeted radioligand therapy such as lutetium-177-PSMA-617. This is crucial for mCRPC patients who have ...

Researchers at the University of Pittsburgh have devised a biomarker test that can spot small amounts of clumping tau protein in the brain and cerebrospinal fluid, which lead to Alzheimer's disease.

Years before tau tangles show up in brain scans of patients with Alzheimer's disease, a biomarker test developed at the ...

Chemistry researchers at Case Western Reserve University have identified specific markers that could pave the way for new ...

A blood-based biomarker test may be a reliable method for predicting or ruling out Alzheimer’s disease-related pathology and ...

While nearly 30,000 Bulgarians need biomarker diagnostics annually, the state only covers the costs of one biomarker for breast cancer.

Years before tau tangles show up in brain scans of patients with Alzheimer's disease, a biomarker test can detect small amounts of the clumping-prone tau protein and its misfolded pathological forms ...